Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together.
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning.
Read about our journey and get to know the leadership team at Vested
ENvue Medical, Inc. is a medical technology company advancing both non-invasive and minimally invasive solutions across clinical and home care settings. Its segments include NanoVibronix, ENvue and Corporate. NanoVibronix is engaged in selling its products directly to patients as well as through distributor agreements. ENvue is engaged in selling its systems and Nasoenteral tubes and related services. The Company focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. more
| Time Frame | FEED | S&P500 | |
|---|---|---|---|
| 1-Week Return | -% | % | -0.48%% |
| 1-Month Return | -% | % | 0.99%% |
| 3-Month Return | -% | % | 3.16%% |
| 6-Month Return | -% | % | 11.21%% |
| 1-Year Return | -% | % | 17.24%% |
| 3-Year Return | -% | % | 80.5%% |
| 5-Year Return | -% | % | 83.81%% |
| 10-Year Return | -% | % | 237.94%% |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| FEED | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| FEED | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
ENvue Medical Inc (FEED) share price today is $2.31
Yes, Indians can buy shares of ENvue Medical Inc (FEED) on Vested. To buy
Yes, you can purchase fractional shares of ENvue Medical Inc (FEED) via the Vested app. You can start investing in ENvue Medical Inc (FEED) with a minimum investment of $1.
You can invest in shares of ENvue Medical Inc (FEED) via Vested in three simple steps:
The 52-week high price of ENvue Medical Inc (FEED) is $. The 52-week low price of ENvue Medical Inc (FEED) is $.
The price-to-earnings (P/E) ratio of ENvue Medical Inc (FEED) is
The price-to-book (P/B) ratio of ENvue Medical Inc (FEED) is 0.00
The dividend yield of ENvue Medical Inc (FEED) is 0.00%
The market capitalization of ENvue Medical Inc (FEED) is $2.51M
The stock symbol (or ticker) of ENvue Medical Inc is FEED
Link copied